Regional binding of tau and amyloid PET tracers in Down syndrome autopsy brain tissue
Open Access
- 23 November 2020
- journal article
- research article
- Published by Springer Nature in Molecular Neurodegeneration
- Vol. 15 (1) , 1-10
Abstract
Introduction: Tau pathology is a major age-related event in Down syndrome with Alzheimer’s disease (DS-AD). Although recently, several different Tau PET tracers have been developed as biomarkers for AD, these tracers showed different binding properties in Alzheimer disease and other non-AD tauopathies. They have not been yet investigated in tissue obtained postmortem for DS-AD cases. Here, we evaluated the binding characteristics of two Tau PET tracers (3H-MK6240 and 3H-THK5117) and one amyloid (3H-PIB) ligand in the medial frontal gyrus (MFG) and hippocampus (HIPP) in tissue from adults with DS-AD and DS cases with mild cognitive impairment (MCI) compared to sporadic AD. Methods: Tau and amyloid autoradiography were performed on paraffin-embedded sections. To confirm respective ligand targets, adjacent sections were immunoreacted for phospho-Tau (AT8) and stained for amyloid staining using Amylo-Glo. Results: The two Tau tracers showed a significant correlation with each other and with AT8, suggesting that both tracers were binding to Tau deposits. 3H-MK6240 Tau binding correlated with AT8 immunostaining but to a lesser degree than the 3H-THK5117 tracer, suggesting differences in binding sites between the two Tau tracers. 3H-THK5117, 3H-MK6240 and 3H-PIB displayed dense laminar binding in the HIPP and MFG in adult DS brains. A regional difference in Tau binding between adult DS and AD was observed suggesting differential regional Tau deposition in adult DS compared to AD, with higher THK binding density in the MFG in adult with DS compared to AD. No significant correlation was found between 3H-PIB and Amylo-Glo staining in adult DS brains suggesting that the amyloid PIB tracer binds to additional sites. Conclusions: This study provides new insights into the regional binding distribution of a first-generation and a second-generation Tau tracer in limbic and neocortical regions in adults with DS, as well as regional differences in Tau binding in adult with DS vs. those with AD. These findings provide new information about the binding properties of two Tau radiotracers for the detection of Tau pathology in adults with DS in vivo and provide valuable data regarding Tau vs. amyloid binding in adult DS compared to AD.Keywords
All Related Versions
Funding Information
- National Institute on Aging (RO1AG061566, P50AD16573, PO01AG014449)
- Stiftelsen för Strategisk Forskning (RB13-0192)
- Alzheimerfonden
- Stiftelsen för Gamla Tjänarinnor
- Gun och Bertil Stohnes Stiftelse
- gunvor och josef anérs stiftelsen
- Loo och Hans Ostermans Stiftelse för Medicinsk Forskning
- Tore Nilsons Stiftelse för Medicinsk Forskning
- ki foundation for geriatrics diseases
- Demensförbundet
- Hrvatska Zaklada za Znanost (IP-2019-04-3584)
- BrightFocus Foundation
- Vetenskapsrådet (Project 05817, 2017-0295, 2017-06086)
- Stockholms Läns Landsting
- Hjärnfonden
This publication has 31 references indexed in Scilit:
- Tau positron emission tomography imaging in tauopathies: The added hurdle of off‐target bindingAlzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 2018
- Neuronal exosomes reveal Alzheimer's disease biomarkers in Down syndromeAlzheimer's & Dementia, 2016
- Frontal Lobe Degeneration in Adults with Down Syndrome and Alzheimer's Disease: A ReviewDementia and Geriatric Cognitive Disorders, 2016
- Aging in Down Syndrome and the Development of Alzheimer's Disease NeuropathologyCurrent Alzheimer Research, 2015
- NIH Image to ImageJ: 25 years of image analysisNature Methods, 2012
- The relationship between acquired impairments of executive function and behaviour change in adults with Down syndromeJournal of Intellectual Disability Research, 2010
- PIB is a non-specific imaging marker of amyloid-beta (A ) peptide-related cerebral amyloidosisBrain, 2007
- Parallel Compensatory and Pathological Events Associated with Tau Pathology in Middle Aged Individuals with Down SyndromeJournal of Neuropathology & Experimental Neurology, 2003
- Oxidation of Aβ and Plaque Biogenesis in Alzheimer's Disease and Down SyndromeNeurobiology of Disease, 2001
- Comparative studies of purified and reconstituted monoamine oxidase from bovine liver mitochondriaBiochimica et Biophysica Acta (BBA) - Biomembranes, 1983